Search

Majumder, P. K., P. G. Febbo, R. Bikoff, R. Berger, Q. Xue, L. M. McMahon, J. Manola, et al. 2004. “MTOR Inhibition Reverses Akt-Dependent Prostate Intraepithelial Neoplasia through Regulation of Apoptotic and HIF-1-Dependent Pathways”. Nat Med 10: 594-601.

McGill, G. G., M. Horstmann, H. R. Widlund, J. Du, G. Motyckova, E. K. Nishimura, Y. L. Lin, et al. 2002. “Bcl2 Regulation by the Melanocyte Master Regulator Mitf Modulates Lineage Survival and Melanoma Cell Viability”. Cell 109: 707-18.

Meyers, R. M., J. G. Bryan, J. M. McFarland, B. A. Weir, A. E. Sizemore, H. Xu, N. V. Dharia, et al. 2017. “Computational Correction of Copy Number Effect Improves Specificity of CRISPR-Cas9 Essentiality Screens in Cancer Cells”. Nat Genet 49: 1779-84.

Moffett, H. F., A. N. R. Cartwright, H. J. Kim, J. Godec, J. Pyrdol, T. Aijo, G. J. Martinez, et al. 2017. “Erratum: The MicroRNA MiR-31 Inhibits CD8(+) T Cell Function in Chronic Viral Infection”. Nat Immunol 18: 1173.

Febbo, P. G., M. Lowenberg, A. R. Thorner, M. Brown, M. Loda, and T. R. Golub. 2005. “Androgen Mediated Regulation and Functional Implications of Fkbp51 Expression in Prostate Cancer”. J Urol 173: 1772-7.

Frohling, S., C. Scholl, R. L. Levine, M. Loriaux, T. J. Boggon, O. A. Bernard, R. Berger, et al. 2007. “Identification of Driver and Passenger Mutations of FLT3 by High-Throughput DNA Sequence Analysis and Functional Assessment of Candidate Alleles”. Cancer Cell 12: 501-13.

Garraway, L. A., H. R. Widlund, M. A. Rubin, G. Getz, A. J. Berger, S. Ramaswamy, R. Beroukhim, et al. 2005. “Integrative Genomic Analyses Identify MITF As a Lineage Survival Oncogene Amplified in Malignant Melanoma”. Nature 436: 117-22.

Golub, T. R. 2001. “Genome-Wide Views of Cancer”. N Engl J Med 344: 601-2.

Golub, T. R. 2003. “Mining the Genome for Combination Therapies”. Nat Med 9: 510-1.

Golub, T. R. 2007. “Genomics: Global Views of Leukaemia”. Nature 446: 739-40.